CJC-1295, a synthetic analog of growth hormone releasing hormone (GHRH), consists of 30 amino acids. It has demonstrated high efficacy in increasing growth hormone secretion and insulin-like growth factor 1 (IGF-1) levels without adversely affecting GH secretion pulsatility.
This peptide is frequently combined with Ipamorelin due to its superior specificity as a GHRH, generating similar growth hormone secretion enhancements without the associated appetite stimulation or increase in cortisol, acetylcholine, prolactin, or aldosterone seen with other peptides in its class. It is well-tolerated and synergizes effectively when paired with Ipamorelin.
Benefits of CJC-1295:
CJC-1295 also facilitates slow wave deep sleep, critical for optimal muscle growth, memory retention, and rejuvenation.
Two types of CJC 1295:
Safety:
Side effects of CJC-1295 may include injection site reactions, headache, diarrhea, vasodilation, nausea, and abdominal pain. Regular monitoring and adherence to prescribed protocols are essential for optimizing benefits while minimizing risks.
1 vial x 10 ml x 500 mg/ml
1 vial x 10 ml x 400 mg/ml
10 ml x 500 mg/ml
